丰原药业 (000153)
ANHUI FENGYUAN PHARMACEUTICAL CO., LTD
K-Line Chart
No K-line data available
Company NameAnhui Fengyuan Pharmaceutical Co., Ltd.
Listing Date2000-09-20
Issue Price18.8RMB
Registered Capital46468.552210k RMB
Legal RepresentativeRu Tianle
Registered AddressNo. 188 Tongjiang Avenue, Wuwei City, Wuhu City, Anhui Province, China
IndustryChemical Pharmaceuticals
Main BusinessThe main business scope includes research, development, production, and sales of biological drugs, traditional Chinese medicines, chemical synthetic drugs and their preparations.
Company ProfileAnhui Fengyuan Pharmaceutical Co., Ltd. is the first listed pharmaceutical company in Anhui Province, integrating pharmaceutical R&D, production, and sales. It is a national high-tech enterprise and one of China's Top 100 Pharmaceutical Industrial Enterprises. The company currently operates 53 production lines certified by GMP. Its products span five major fields: biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, prepared slices of Chinese crude drugs, and active pharmaceutical ingredients (APIs). They cover seven major categories including antipyretic analgesics, women's and children's health, nervous system, cardiovascular system, urinary system, nutrition, and antibiotics, with over 10 dosage forms and more than 300 varieties. The company possesses several national Class I and II new drug varieties and holds independent intellectual property rights for multiple products. It operates a chain of over 500 pharmacies across the province.
Stock Details
1. Key Indicators
- Total Shares(W): 46477.37
- Circulating A-Shares(W): 46055.62
- Earnings Per Share(RMB): 0.2158
- Net Assets Per Share(RMB): 4.5217
- Operating Revenue(W RMB): 312514.58
- Total Profit(W RMB): 11395.00
- Net Profit Attributable to Parent(W RMB): 10028.43
- Net Profit Growth Rate(%): -31.92
- Weighted Return on Equity(%): 4.8500
- Operating Cash Flow Per Share(RMB): 0.1910
- Undistributed Profit Per Share(RMB): 2.2460
- Capital Reserve Per Share(RMB): 0.9857
2. Main Business
The main business covers:
- Pharmaceutical Manufacturing
- Commercial Distribution
3. Company Basic Information
- Company Name: Anhui Fengyuan Pharmaceutical Co., Ltd.
- Listing Date: 2000-09-20
- Industry: Pharmaceutical Manufacturing
- Address: No. 16 Dalian Road, Baohe District, Hefei City, Anhui Province
- Website: www.bbcayy.com
- Company Profile：The company was established on August 30, 1997, as a joint-stock company initiated by five legal entities. Its initial total share capital was 2,060.4 thousand shares. On November 28, 1998, the company conducted a capital increase and share expansion, with new shares subscribed by Anhui Bengbu Tushan Pharmaceutical Factory, Anhui Ma'anshan Biochemical Pharmaceutical Factory, and Anhui Pharmaceutical Research Institute. After the capital increase, the registered capital of the joint-stock company changed to 4,000.23 thousand yuan. Following the successful public issuance of 2,500 thousand RMB ordinary shares on September 7, 2000, the company's total share capital reached 6,500.23 thousand shares. The business license number is 340000000005174.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Anhui Wuwei Pharmaceutical Factory | General Legal Person | 5017.90 | 11.09 |
| 2 | Bengbu Tushan Enterprise Management Co., Ltd. | General Legal Person | 3573.07 | 7.90 |
| 3 | Hainan Guihedayi Investment Partnership (Limited Partnership) | General Legal Person | 2369.86 | 5.24 |
| 4 | Ma'anshan Fengyuan Enterprise Management Co., Ltd. | General Legal Person | 2336.75 | 5.17 |
| 5 | Great Wall Guorong Investment Management Co., Ltd. | General Legal Person | 579.60 | 1.28 |
| 6 | <值> | <值> | <值> | <值> |
| 7 | <值> | <值> | <值> | <值> |
| 8 | <值> | <值> | <值> | <值> |
| 9 | <值> | <值> | <值> | <值> |
| 10 | <值> | <值> | <值> | <值> |
5. Concept Sectors
- Venture Capital Concept
- Vitamins
- Generic Drugs
- Sugar Substitute Concept
- Equity Transfer
- Micro-cap Selection
- Micro-small Cap Stocks
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information